Original document(58 pages)  中文版
    N-(Sulfonyloxybiarylmethyl)aminocyclopropanecarboxamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
Application Number
申请号		 200480022661 Application Date
申请日		 2004.08.03
Title 名称 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides
Publication Number
公开号		 1832922 Publication Date
公开日		 2006.09.13
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D213/02,A61K31/44
Applicant(s) Name
申请人		 Merck & Co. Inc.
Address 地址
Inventor(s) Name 发明人 Anthony Neville J., Gomez Robert, Jolly Samson M., Lim John Jin
Attorney & Agent 代理人 guo yu wang jingchao

  
Method for the manufacture of cyanopyridines and catalysts suitable therefor
Aluminum chelate complex for organic el material
New p2x7 receptor avtagonists and their use
6-(2,2,2-trifluoroethylamino)-7-chloro-2,3,4,5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
Novel gamma-secretase inhibitors
5-membered heterocycle-based p38 kinase inhibitors
2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
Amide derivative
A process for the preparation of phenyltetrazole derivatives
Biaryl heterocyclic compounds and methods of making and using the same
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.